RCAG
MNTA

Rehmann Capital Advisory Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Rehmann Capital Advisory Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-74
Closed -$1.95K – 2210
2018
Q3 		$1.95K Buy
74
+30
+68% +$811 ﹤0.01% 1818
2018
Q2 		$900 Sell
44
-9
-17% -$193 ﹤0.01% 1994
2018
Q1 		$1K Buy
+53
New +$884 ﹤0.01% 1972

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Rehmann Capital Advisory Group's MNTA Position: Q4 2018 in Review

Rehmann Capital Advisory Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2018, closing a stake of 74 shares — an estimated $1.95K sold.

Rehmann Capital Advisory Group first reported a position in MNTA in Q1 2018 and held it in 3 quarters. The position peaked at $1.95K in Q3 2018. 158 funds tracked by Wall St. Rank hold MNTA as of Q4 2018.

  • Rehmann Capital Advisory Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 74 Momenta Pharmaceuticals, Inc. shares in Q4 2018, an estimated $1.95K.
  • Rehmann Capital Advisory Group first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 3 quarters.
  • Rehmann Capital Advisory Group's Momenta Pharmaceuticals, Inc. position peaked at $1.95K in Q3 2018.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2018.

Based on Rehmann Capital Advisory Group's 13F filing for Q4 2018, filed 12 Feb 2019.